Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice

This publication has 45 references indexed in Scilit:

• Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β
  Journal of Biological Chemistry, 2001
• Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo
  Journal of Biological Chemistry, 2001
• Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 Cells
  Biochemical and Biophysical Research Communications, 2000
• Coronary Heart Disease: Reducing the Risk
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages
  Journal of Biological Chemistry, 1998
• Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
  Journal of Clinical Investigation, 1996
• Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
  Science, 1992
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
  Published by Elsevier ,1992
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987